Form D · Biotechnology
REPROS THERAPEUTICS INC.
Woodlands, TX · CIK 0000897075
Offering snapshot reported Sep 19, 2012 · SEC filing
- Reported sold
- $23.6M Offering amount: $23.6M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 7, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 19, 2012 | Initial | $23,601,997 | No comparison | 15 | SEC filing |
| Nov 12, 2009 | Initial | $5,897,313 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $300K
- Finders' fees
- $0
- Form D file number
- 021-184301
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Trout Capital LLC | 131489 | Trout Capital LLC · CRD 131489 |
Source: Form D, filed Sep 19, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Katherine Anderson | Executive |
| Daniel Cain | Director |
| Jean Fourcroy | Director |
| Mark Lappe | Director |
| Nola Masterson | Director |
| Joseph S. Podolski | Director, Executive |
| Jaye Thompson, Ph.D. | Director |
| Michael Wyllie, Ph.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2408 Timberloch Pl Suite B 7
Woodlands, TX, 77380
Woodlands, TX, 77380